Back to search
FDAFDA · Food and drugs·Recall number D-1186-2018

Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01

Published September 19, 2018 · Recall initiated: August 7, 2018

Summary

FDA records drug Class III recall D-1186-2018, published September 19, 2018 and initiated August 7, 2018. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 11,799 bottles of 100; Lot: Batch code # 3093163, expiration date 04/2019. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Pharmaceuticals Inc.
Distributor
Distributed Nationwide in the US
Lot
Batch code # 3093163, expiration date 04/2019
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Diltiazem HCl Extended-Release Capsules, USP 120 mg 100-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505. NDC 0378-5220-01 recalled?

Yes. FDA published recall D-1186-2018 on September 19, 2018. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification test results obtained during routine stability testing for related compound.

What should I do if I have this product?

Voluntary: Firm initiated · Letter